Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease

NCT01387178 · clinicaltrials.gov ↗

COMPLETED

Status

22223

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: fluticasone propionate/salmeterol 250µg/50µg (FSC)
DRUG: tiotropium bromide (TIO)

Sponsor

GlaxoSmithKline